FDA gives AFT Pharma drug the OK

Nov 1, 2021 | Latest News

1.11.21   AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announced the US Food and Drug Administration (FDA) has confirmed acceptance of the New Drug Application (NDA) for Maxigesic IV®, the intravenous form of its patented pain relief medicine which was filed in August this year. AFT shares jumped 30c to $4.40. The US regulator is expected, in […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options